Happy second anniversary, Retraction Watch: Plus, our plans for year three

We didn’t plan it this way, but our second anniversary gift came a few days early this week, when we learned that a retraction notice had cited us. Given that the traditional second anniversary gift is cotton, and we’re really not sure what to do with that information, we’re much happier — and humbled — by the mention.

Two years ago today, we launched Retraction Watch. When we looked back at year one, we had written more than 250 posts; that number is up to more than 600. We had a new record-holder in our first year, Joachim Boldt, with 88 retractions; we now have a new one, Yoshitaka Fujii, with 172 likely. This July, we crossed the three million-pageview threshold, and also saw our first 300,000-pageview month.

But numbers don’t always tell the whole story, Continue reading Happy second anniversary, Retraction Watch: Plus, our plans for year three

Family Practice affair: Diabetes paper pulled for redundancy, which journal calls “honest error”

Family Practice has retracted a 2009 review article on diabetes whose author had published a similar — in spots identical — paper two years earlier in another journal. We think the notice is nine-tenths solid, but there’s a part at the end that raises an important question about how much, or little, editors should do to accommodate the embarrassments of their authors.

The notice:

Continue reading Family Practice affair: Diabetes paper pulled for redundancy, which journal calls “honest error”

Transparency in action: EMBO Journal detects manipulated images, then has them corrected before publishing

As Retraction Watch readers know, we’re big fans of transparency. Today, for example, The Scientist published an opinion piece we wrote calling for a Transparency Index for journals. So perhaps it’s no surprise that we’re also big fans of open peer review, in which all of a papers’ reviews are made available to readers once a study is published.

Not that many journals have taken this step — medical journals at BioMedCentral are among those that have, and they even include the names of reviewers — but a recent peer review file from EMBO Journal, one publication that has embraced this transparent approach, is particularly illuminating.

Alan G. Hinnebusch, of the U.S. Eunice Kennedy Shriver National Institute of Child Health and Human Development, submitted a paper on behalf of his co-authors on November 2, 2011, at which point it went out for peer review. The editors sent those reviews back to the author on January 2, 2012, and Hinnebusch responded with revisions on April 4. So far, the process looks much like that any scientist goes through — questions about methods, presentation, and conclusions, followed by answers from the authors.

But what caught the eye of frequent Retraction Watch commenter Dave, who brought this to our attention, was what happened starting on May 18 when the editors responded to the authors again. (That letter is labeled as page 6, but is actually page 16 of the linked document.): Continue reading Transparency in action: EMBO Journal detects manipulated images, then has them corrected before publishing

Psychological Science retracts a Sanna paper, citing lawyers, COPE…and Retraction Watch

In April 2011, we praised Psychological Science for its handling of a retraction. At the time, we went as far as to call the retraction notice a “model” of transparency for other journals to follow.

Well, they evidently took that compliment seriously, according to a new retraction notice for a paper by Lawrence Sanna. Sanna left Michigan under a cloud a few months ago after another scientist found his data statistically implausible, as Ed Yong reported in Nature.

The newly retracted paper, “Construing collective concerns: Increasing cooperation by broadening construals in social dilemmas,” was published in 2009 while Sanna was still at the University of North Carolina-Chapel Hill. Here’s a sample from the abstract: Continue reading Psychological Science retracts a Sanna paper, citing lawyers, COPE…and Retraction Watch

Cancer journal pulls deeply flawed meeting abstract on breast surgery

The European Journal of Surgical Oncology has retracted a meeting abstract that evidently was never meant to be.

The study, by researchers at Queen Elizabeth Hospital and Good Hope Hospital, both in Birmingham, England, was to be presented at this year’s annual meeting of the Association of Breast Surgery and purported to compare rates of patient satisfaction among women who underwent two kinds of breast reconstruction, TRAM — transverse rectus abdominis myocutaneous  — flap and DIEP (short for deep inferior epigastric perforators) flap.

But according to the notice: Continue reading Cancer journal pulls deeply flawed meeting abstract on breast surgery

Prostate cancer researcher who retracted two studies at center of lawsuit departs Hopkins

Robert Getzenberg, the Johns Hopkins prostate cancer researcher who has recently retracted two papers involved in work he was sued over, has left the university, Retraction Watch has learned.

Getzenberg, who directed the Research Laboratories at the Hopkins’ Brady Urological Institute, has been working on an alternative to the prostate-specific antigen (PSA) test. In 2009, he — along with Hopkins and Pitt, his former employer — was sued by a company that funded his work, Science magazine reported at the time. The suits were eventually settled for an undisclosed amount, and Getzenberg and his colleagues have now retracted two papers, one in Urology and one in The Prostate, as we’ve reported. Continue reading Prostate cancer researcher who retracted two studies at center of lawsuit departs Hopkins

Statins without prescription website paper retracted after company says it requires scripts, threatens suit

The authors of a paper on websites that sell cholesterol-lowering statin medications without prescriptions have retracted it. The move followed the threat of a lawsuit against the journal by a company included in the study that says it never dispenses sans a script.

Here’s the notice: Continue reading Statins without prescription website paper retracted after company says it requires scripts, threatens suit

Plagiarism topples paper co-authored by top tamoxifen scientist

Expert Opinion on Pharmacotherapy has retracted a 2011 paper for plagiarism by two authors, one of whom, V. Craig Jordan, is a leading researcher on the class of drugs known as selective estrogen receptor modulators, or SERMs, and is credited with discovering the anti-tumor properties of the breast cancer drug tamoxifen.

Jordan, who is scientific director at the Lombardi Comprehensive Cancer Center at Georgetown University, appears to have been unaware of the offense when the paper was published. Here’s the notice: Continue reading Plagiarism topples paper co-authored by top tamoxifen scientist

Ovarian transplant update: Authors of 2004 live-birth follow-up letter ask Lancet to retract it

Yesterday, we brought you news of a story in Belgium involving questions about whether a woman who gave birth following an ovarian transplant could have become pregnant without the transplant. The case, which led to a university investigation but no retraction, included allegations of theft and arson.

This morning, we were made aware of a request for a retraction from The Lancet related to other work by Jacques Donnez, the obstetrician-gynecologist at the center of the case. In 2004, Donnez and colleagues published what they said was the first pregnancy using frozen banked ovarian tissue in The Lancet. The paper has been cited hundreds of times, but not everyone agreed with Donnez et al’s assessment at the time. All but one of the authors of a Lancet letter — colleagues of Donnez’s at the Catholic University of Louvain — describing the perinatal follow-up of the woman now say they don’t either, and want to retract their letter.

In their letter requesting retraction, published in the journal on July 14, Corinne Hubinont and colleagues write that they “did not have access to the patient’s gynaecological records throughout the pregnancy,” but that “Recently, we had the opportunity to read the patient’s notes,” which include a progesterone measurement “omitted by Donnez and colleagues:” Continue reading Ovarian transplant update: Authors of 2004 live-birth follow-up letter ask Lancet to retract it

Buyer beware: Conflict Resolution Quarterly pulls paper for plagiarism

Conflict Resolution Quarterly, which we probably all should read but don’t, is retracting a 2010 paper on commercial interactions by a French researcher who combined two other articles into a work he called his own.

But, true to its name, the journal takes a more, shall we say, diplomatic approach to the affair.

Here’s the notice (which, tsk tsk, is behind a paywall): Continue reading Buyer beware: Conflict Resolution Quarterly pulls paper for plagiarism